Quarterly report pursuant to Section 13 or 15(d)

Benefit Plans (Tables)

v3.24.1.u1
Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
Schedule of Fair Value of Options Granted
The following table summarizes the weighted-average assumptions used to compute the fair value of options granted to employees, members of our board of directors and non-employees:

  For the Three Months Ended March 31,
  2024 2023
Risk-free interest rate 4.2% 4.0%
Expected life of options — years 3.76 3.80
Expected stock price volatility 39% 31%
Expected dividend yield 2.1% 1.9%
Schedule of Stock Options Activity Under Share-based Payment Plans
The following table summarizes stock option activity under our share-based plans for the three months ended March 31, 2024:
  Options Weighted-Average
Exercise Price
Per Share
Weighted-Average
Remaining
Contractual Term (Years)
Aggregate
Intrinsic
Value
Outstanding as of December 31, 2023 122  $ 5.60 
Granted 17  $ 5.13 
Exercised (1) $ 3.81 
Forfeited, cancelled or expired (1) $ 5.82 
Outstanding as of March 31, 2024 137  $ 5.55  5.16 $
Exercisable as of March 31, 2024 95  $ 5.56  4.19 $
Schedule of Restricted Stock Unit and Stock Award Activity
The following table summarizes the restricted stock unit, including PRSU, activity under our share-based plans for the three months ended March 31, 2024:
  Shares Grant Date
Fair Value Per Share
Nonvested as of December 31, 2023 89  $ 5.59 
Granted $ 5.17 
Vested (7) $ 6.09 
Forfeited (4) $ 5.63 
Nonvested as of March 31, 2024 86  $ 5.49